Description of blood Analysis: 

Plasma Free Metanephrines are the metabolic byproducts of catecholamines (epinephrine and norepinephrine), which are hormones produced by the adrenal medulla in response to stress. Unlike the parent hormones, which are released in short-lived pulses and disappear quickly, metanephrines are produced continuously by the adrenal tissue and remain stable in the bloodstream for a longer duration. In clinical diagnostics, measuring plasma metanephrines is considered the most sensitive test for identifying rare neuroendocrine tumors, such as pheochromocytomas or paragangliomas. Because these tumors often leak metanephrines into the blood even when they are not actively secreting hormones, this test is an essential tool for ruling out or confirming a tumor as the cause of severe hypertension or “adrenal-like” symptoms.

What does the analysis represent?

• Purpose: To quantify the stable metabolites of adrenaline and noradrenaline to detect overactive neuroendocrine tissue.
• Primary Application: Screening for pheochromocytoma and paraganglioma, especially in patients with resistant hypertension, headaches, or heart palpitations.
• Method: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) using a venous blood sample.

Recommendations for the Test (General)

• Timing: Usually performed in the morning.
• Fasting: 8–10 hours recommended; water permitted.
• Rest: The patient must remain in a supine (lying down) position for at least 20–30 minutes before the blood draw to ensure basal levels are measured.
• Specific Rules: Refrain from caffeine (coffee, tea, energy drinks), nicotine, and alcohol for at least 24 hours prior. This analysis has strict handling requirements: blood must be collected in a pre-chilled EDTA tube (purple top), immediately placed on ice, and centrifuged in a refrigerated environment.

What can affect the results?

• Factors altering levels: Intense stress, pain, or recent physical exertion can cause a physiological rise in metanephrines.
• Conversely: Many medications, including certain antidepressants (TCAs, SNRIs), decongestants, and some blood pressure medications, can cause falsely elevated results. Discuss all medications with your physician before the test.

When to take the test?

• Recommendations: This test is requested when a patient experiences “paroxysmal” symptoms (sudden episodes) of high blood pressure, rapid heartbeat, sweating, and tremors, or when an adrenal mass is discovered accidentally on imaging.
• Preparation: It is crucial to follow the “supine” protocol and dietary restrictions, as failure to do so is the most common cause of false-positive results.

How to interpret the results?

• The interpretation of your laboratory results is the exclusive responsibility of a qualified physician.
• A metanephrine value should not be viewed in isolation; if results are only mildly elevated, your doctor may suggest repeat testing or a “clonidine suppression test.”
• Only a professional medical review can integrate these findings with your clinical history and imaging results to determine the presence of a neuroendocrine tumor.

Possible further investigations

• 24-Hour Urinary Metanephrines: To provide a cumulative measure of metabolite excretion over a full day.
• Chromogranin A: An additional general marker for neuroendocrine tumors.
• CT or MRI of the Abdomen: To physically locate an adrenal or extra-adrenal mass.
• Endocrinology Consultation: To develop a specialized diagnostic and surgical management plan.

When does the next step make sense?

• If plasma metanephrine levels are significantly elevated (typically more than twice the upper limit of normal), the findings are reviewed by a physician to prioritize localization of the tumor via imaging.
• All medical decisions are personalized based on the patient’s symptom severity and genetic risk profile.

👉 If necessary, you can discuss the analysis results with a specialist such as an endocrinologist (Doctors – TAMC).